Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
Objective: Opioid use disorder is a prevalent addiction problem that can be treated with buprenorphine, but dependence, diversion, and abuse of buprenorphine occur. Although including naloxone reduces these problems, the combination formulation is not available worldwide. The administration of the m...
Saved in:
| Main Authors: | Jamshid Ahmadi, Ebrahim Moghimi Sarani, Mina Sefidfard Jahromi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Tzu Chi Medical Journal |
| Subjects: | |
| Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2020;volume=32;issue=1;spage=58;epage=64;aulast=Ahmadi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report
by: Ezioma Gbujie, et al.
Published: (2025-06-01) -
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
by: Arash Mansoori, et al.
Published: (2025-04-01) -
Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study
by: Avinash Jhajharia, et al.
Published: (2025-04-01) -
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
by: Kathleen K. Adams, et al.
Published: (2025-02-01)